A61K 9/0014
Skin, i.e. galenical aspects of topical compositions
Official title: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
A61K9/0014 (Skin, i.e. galenical aspects of topical compositions) appears on 9,328 US grants and 15,745 published applications in this corpus.
Search patents in A61K- Granted patents
- 9,328
- Published applications
- 15,745
- Assignees
- 5,632
- Inventors
- 21,196
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 24 | 0 |
| 1977 | 27 | 0 |
| 1978 | 27 | 0 |
| 1979 | 20 | 0 |
| 1980 | 20 | 0 |
| 1981 | 23 | 0 |
| 1982 | 24 | 0 |
| 1983 | 33 | 0 |
| 1984 | 38 | 0 |
| 1985 | 36 | 0 |
| 1986 | 29 | 0 |
| 1987 | 41 | 0 |
| 1988 | 40 | 0 |
| 1989 | 73 | 0 |
| 1990 | 70 | 0 |
| 1991 | 82 | 0 |
| 1992 | 83 | 0 |
| 1993 | 78 | 0 |
| 1994 | 57 | 0 |
| 1995 | 71 | 0 |
| 1996 | 93 | 0 |
| 1997 | 122 | 0 |
| 1998 | 109 | 0 |
| 1999 | 122 | 0 |
| 2000 | 103 | 0 |
| 2001 | 112 | 52 |
| 2002 | 141 | 181 |
| 2003 | 107 | 258 |
| 2004 | 91 | 286 |
| 2005 | 81 | 319 |
| 2006 | 84 | 309 |
| 2007 | 73 | 298 |
| 2008 | 69 | 378 |
| 2009 | 85 | 372 |
| 2010 | 140 | 514 |
| 2011 | 145 | 489 |
| 2012 | 202 | 574 |
| 2013 | 339 | 645 |
| 2014 | 429 | 785 |
| 2015 | 429 | 746 |
| 2016 | 488 | 950 |
| 2017 | 549 | 1000 |
| 2018 | 556 | 884 |
| 2019 | 550 | 1034 |
| 2020 | 582 | 1060 |
| 2021 | 559 | 1034 |
| 2022 | 533 | 935 |
| 2023 | 435 | 826 |
| 2024 | 421 | 744 |
| 2025 | 452 | 642 |
| 2026 | 231 | 430 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Topical anaesthetic composition having improved vasoconstrictor stability6 Oct 2026US 12,751,946 B2Animal Ethics Pty Ltd
- Cannabidiol nanodrug formulations and methods for use of the same6 Oct 2026US 12,751,959 B2University of Miami
- Ionic liquids for transdermal drug delivery6 Oct 2026US 12,752,009 B2Arizona Board of Regents
- Amorphous substances, crystals, pharmaceutical compositions, preparation methods and uses of thiohydantoin compound or pharmaceutically acceptable salt thereof6 Oct 2026US 12,753,173 B2Suzhou Kintor Pharmaceuticals, Inc.
- Anti-sleep disorder article29 Sep 2026US 12,746,147 B2Fine Cotton Factory Inc.
- Composition and Method for Topical Trans-spinal Delivery of Nucleic Acids and Small Molecules8 Oct 2026US 2026/0306414 A13P Biotechnologies, Inc.
- Silica-based nanoparticles for sustained release of hydrophobic drug, preparation method therefor, and transdermal drug delivery system comprising same8 Oct 2026US 2026/0306418 A1Mpios Inc.
- Combination treatment for netherton syndrome8 Oct 2026US 2026/0306448 A1Quoin Pharmaceuticals, Inc.
- Process for preparing dispensable testosterone cream8 Oct 2026US 2026/0306510 A1Lawley Pharmaceuticals Pty Ltd.
- Topical composition8 Oct 2026US 2026/0306512 A1Api Corporation
Most cited
By later US patents
- Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site1,449US 7,718,180 B22010
- Mesocellular oxide foams as hemostatic compositions and methods of use1,075US 8,202,549 B2The Regents of the University of California · 2012
- N[.omega.,(.omega.-1)-dialkyloxy]- and N-[.omega.,(.omega.-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor740US 4,897,355 ASyntex (U.S.A.) Inc. · 1990
- Cationic lipids for intracellular delivery of biologically active molecules586US 5,459,127 AVical Incorporated · 1995
- Cationic lipids for intracellular delivery of biologically active molecules545US 5,264,618 AVical Incorporated · 1993